GeneCentric Diagnostics
Labcorp, GeneCentric Partnering on Development of RNA-Based Cancer Diagnostics
The parties will use retrospective analyses of Labcorp samples, and Labcorp will deploy tests produced through the project to academic and community cancer centers.
GeneCentric, Erasmus University to Research RNA Biomarkers, Therapies for Bladder Cancer
GeneCentric and Erasmus will aim to identify RNA-based drug response markers for existing bladder cancer treatments, as well as discover novel targeted therapies.
Pancreatic Cancer Action Network, GeneCentric Therapeutics Launch Research Partnership
The collaboration seeks to develop RNA-based signatures that could help oncologists predict disease progression and guide the use of precision therapies.
GeneCentric Therapeutics to Launch Phase II Validation Study for Head and Neck Cancer Subtyper
Premium
The firm is developing a biomarker panel to detect mutations in mesenchymal cells, with the goal of guiding drug treatment and improving earlier patient intervention.
GeneCentric, UNC Collaborate on Bladder Cancer Immunotherapy Response Study
The partners will evaluate patients' responses to immunotherapeutic drugs, including PD-1 and PDL-1 inhibitors, based on bladder cancer subtypes.